BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

UCB Pharma (UCBJF.PK) To Test Arthritis Drug Cimzia Against Abbott Laboratories (ABT)'s Humira


5/26/2011 6:52:02 AM

Belgian pharmaceutical company UCB SA (UCB.BT) Wednesday said it will test its flagship rheumatoid arthritis drug Cimzia in a head-to-head clinical trial against Abbott Laboratories' (ABT) anti-inflammatory drug Humira.

UCB hopes the trial will reflect well on Cimzia, which had sales last year of EUR198 million (about $280 million) and is one of three core products on which the Belgium-based drug maker is betting to boost sales, offsetting the loss of patents on older blockbusters.

"We believe the study will provide additional evidence that the ability to make an informed and early treatment decision is important for the treatment of this severe and progressing disease," UCB's chief medical officer Iris Loew-Friedrich said in a statement.


UCB Pharma
Abbott
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES